KLRC1 and lung cancer: The consistent result was also reported in the study by Chen et al. who further found that NKG2A + CD8+ T cells form the predominant subset of NKG2A+ cells in lung cancer tissue but not NK cells and NKG2A blockade could promote anti-tumor immunity by reducing dysfunctional CD8+ T cells16.